However, the significant increase in SOD and GSH-Px activities was observed only in metabolic syndrome rats with cerebral ischemia which received OA extract at dose of 50 mg/kg BW (P value < 0.05 and 0.01, respectively, compared to the HCHF+MCAO+vehicle group). This evidence concerns the gene SOD1 and metabolic syndrome.